PNN DigitalPNN Digital
    Facebook Twitter Instagram
    Wednesday, June 25
    Trending
    • Gracias Living Launches Emotion-Responsive Dementia Care Unit in Gurgaon
    • India’s Development March: From Spiritual Roots to Strategic Tech! A Unified Vision for a Viksit Bharat
    • National Conference on Unity for Growth – A Collective March Towards Viksit Bharat
    • Sri Shankari Yoga Institute Marks 13 Years with International Yoga Day And New World Record Celebration
    • Shaping the Future: The 2025 Indian Business Excellence Award Winners
    • Moving Media Entertainment Limited IPO Opens on June 26, 2025
    • Pushpa Jewellers Limited IPO Opens on June 30, 2025
    • AVP Infracon Secures Infra Work Order Worth Rs 33.34 Cr from Reliance Mappedu Multi Modal Logistics Park
    Submit News
    PNN DigitalPNN Digital
    Subscribe
    • Home
    • News
    • Business
    • Entertainment
    • National
    • Lifestyle
    • More
      • Sports
      • Health
      • Finance
      • Education
    PNN DigitalPNN Digital
    Home»Business

    Remlife Global Partners With JiyaYu Lifesciences To Replace Animal Inputs In APIs Via Green Chemistry

    A transformative alliance to eliminate animal-origin inputs in API production through innovative fermentation and biocatalysis.
    PNN DigitalPNN Digital Business 3 Mins Read
    Remlife
    Remlife Global and JiyaYu Lifesciences Seal Green Chemistry Partnership in Singapore
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi [India], May 9: Remlife Global PTE LTD., a Singapore-based subsidiary of BSE-listed Remedium Lifecare Ltd. (India), is pleased to announce a forward-looking partnership with JiyaYu Lifesciences PTE Ltd., a green chemistry technology platform company. This collaboration is focused on replacing animal-origin raw materials in the manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates through proprietary fermentation and biocatalyst-based alternatives.

    As part of the partnership, JiyaYu will license out fully developed and scalable technologies to Remlife Global on an exclusive basis. These technologies are designed to replace traditional animal-derived steps with sustainable, cost-effective, and regulatorycompliant bioprocesses. Remlife Global will scale up and commercialise these technologies at one or more GMP-compliant contract manufacturing sites across India, Singapore, Malta, Ireland, Belgium, and Italy.

    JiyaYu Lifesciences has in turn partnered with a UK-based R&D technology platform specialising in the development of fermentation and biocatalystbased alternatives to animal-origin pharmaceutical inputs. Through this collaboration, JiyaYu gains access to cutting-edge innovations that it will transfer to Remlife Global as fully scalable technologies.

    Each technology will be supported by detailed process dossiers and full technology transfer documents, enabling Remlife Global to implement, validate, and scale up the processes at approved GMP manufacturing sites.

    These solutions will support Remlife Global’s vision of eliminating dependence on vulnerable and ethically complex supply chains, while capturing new commercial opportunities in global regulated markets.

    “Our collaboration with JiyaYu Lifesciences is a transformative move toward building a more ethical, resilient, and sustainable pharmaceutical supply chain.” said Adarsh Munjal.

    Financial Outlook

    Each technology platform has a minimum commercial potential of ₹50 crore per product, with EBITDA margins estimated between 20% to 25%. Assuming a scale-up of two products per year, cumulative revenue and EBITDA could grow substantially:

    • FY26: 2 products | ₹100 Cr revenue | ₹20–25 Cr EBITDA
    • FY27: 4 products | ₹200 Cr revenue | ₹40–50 Cr EBITDA

    Moving Beyond Animal-Based Inputs

    Remlife Global’s strategic direction is anchored in the belief that the future of pharmaceuticals lies in sustainable, animal-free production. Key reasons for this shift include:

    • Ethical and ESG Alignment: Modern pharmaceutical companies are under growing pressure to remove animal-based components from their supply chains.
    • Safety & Quality Control: Fermentation and biocatalyst-based systems offer superior consistency and eliminate the risk of contamination from animal-borne pathogens.
    • Supply Chain Resilience: Diseases, regulatory shifts, and geopolitical volatility all threaten the availability of animal-derived inputs.
    • Environmental Benefits: Traditional animal-derived raw materials are linked to high emissions, land use, and water consumption.
    • Industry Momentum: Leading global pharma firms are rapidly adopting bio-based and cruelty-free technologies in their development pipelines.

    About Remlife Global PTE LTD.

    Remlife Global PTE LTD. is the international innovation arm of Remedium Lifecare Ltd. (India), a BSE-listed pharmaceutical company. With a focus on R&D commercialisation and strategic collaborations, Remlife Global is driving the transition to sustainable API Contract manufacturing across multiple global jurisdictions.

    Media Contact

    Adarsh Munjal

    Remlife Global PTE LTD.

    Email: [email protected]

    If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

    APIs Green Chemistry Partners With JiyaYu Lifesciences Remlife Global Replace Animal Inputs
    PNN Digital
    • Website

    Keep Reading

    Gracias Living Launches Emotion-Responsive Dementia Care Unit in Gurgaon

    National Conference on Unity for Growth – A Collective March Towards Viksit Bharat

    Sri Shankari Yoga Institute Marks 13 Years with International Yoga Day And New World Record Celebration

    Shaping the Future: The 2025 Indian Business Excellence Award Winners

    Moving Media Entertainment Limited IPO Opens on June 26, 2025

    Pushpa Jewellers Limited IPO Opens on June 30, 2025

    Recent Posts
    • Gracias Living Launches Emotion-Responsive Dementia Care Unit in Gurgaon
    • India’s Development March: From Spiritual Roots to Strategic Tech! A Unified Vision for a Viksit Bharat
    • National Conference on Unity for Growth – A Collective March Towards Viksit Bharat
    • Sri Shankari Yoga Institute Marks 13 Years with International Yoga Day And New World Record Celebration
    • Shaping the Future: The 2025 Indian Business Excellence Award Winners

    Gracias Living Launches Emotion-Responsive Dementia Care Unit in Gurgaon

    24/06/2025

    India’s Development March: From Spiritual Roots to Strategic Tech! A Unified Vision for a Viksit Bharat

    24/06/2025

    National Conference on Unity for Growth – A Collective March Towards Viksit Bharat

    24/06/2025

    Sri Shankari Yoga Institute Marks 13 Years with International Yoga Day And New World Record Celebration

    24/06/2025

    Shaping the Future: The 2025 Indian Business Excellence Award Winners

    24/06/2025

    Moving Media Entertainment Limited IPO Opens on June 26, 2025

    24/06/2025
    Facebook Instagram Twitter
    • Legal Disclaimer
    • Privacy Policy
    • Contact Us
    • About Us
    © 2025 PNN Digital. Designed by Primex Media Services.

    Type above and press Enter to search. Press Esc to cancel.